146 related articles for article (PubMed ID: 24283059)
1. [Borderline ovarian tumours: a challenge for clinicians].
Nacheva A; Atanasova V; Miloshov V; Ganovska A; Simeonova C
Akush Ginekol (Sofiia); 2013; 52(3):27-30. PubMed ID: 24283059
[TBL] [Abstract][Full Text] [Related]
2. Borderline ovarian tumors: features and controversial aspects.
Messalli EM; Grauso F; Balbi G; Napolitano A; Seguino E; Torella M
Eur J Obstet Gynecol Reprod Biol; 2013 Mar; 167(1):86-9. PubMed ID: 23219291
[TBL] [Abstract][Full Text] [Related]
3. Conservative surgery in ovarian borderline tumours: a meta-analysis with emphasis on recurrence risk.
Vasconcelos I; de Sousa Mendes M
Eur J Cancer; 2015 Mar; 51(5):620-31. PubMed ID: 25661104
[TBL] [Abstract][Full Text] [Related]
4. Frozen section in borderline ovarian tumors: is it reliable?
Ureyen I; Turan T; Cirik DA; Tasci T; Boran N; Bulbul D; Tulunay G
Eur J Obstet Gynecol Reprod Biol; 2014 Oct; 181():115-8. PubMed ID: 25145763
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic accuracy of intraoperative consultation (frozen section) in borderline ovarian tumours and factors associated with misdiagnosis.
Basaran D; Salman MC; Calis P; Ozek A; Ozgul N; Usubütün A; Yuce K
J Obstet Gynaecol; 2014 Jul; 34(5):429-34. PubMed ID: 24734941
[TBL] [Abstract][Full Text] [Related]
6. Malignant and borderline epithelial ovarian tumors in the pediatric and adolescent population.
Nasioudis D; Alevizakos M; Holcomb K; Witkin SS
Maturitas; 2017 Feb; 96():45-50. PubMed ID: 28041594
[TBL] [Abstract][Full Text] [Related]
7. Comparison of tumor markers and clinicopathological features in serous and mucinous borderline ovarian tumors.
Alanbay I; Aktürk E; Coksuer H; Ercan CM; Karaşahin E; Dede M; Yenen MC; Ozan H; Dilek S
Eur J Gynaecol Oncol; 2012; 33(1):25-30. PubMed ID: 22439401
[TBL] [Abstract][Full Text] [Related]
8. Borderline tumours of the ovary: A cohort study of the Arbeitsgmeinschaft Gynäkologische Onkologie (AGO) Study Group.
du Bois A; Ewald-Riegler N; de Gregorio N; Reuss A; Mahner S; Fotopoulou C; Kommoss F; Schmalfeldt B; Hilpert F; Fehm T; Burges A; Meier W; Hillemanns P; Hanker L; Hasenburg A; Strauss HG; Hellriegel M; Wimberger P; Keyver-Paik MD; Baumann K; Canzler U; Wollschlaeger K; Forner D; Pfisterer J; Schröder W; Münstedt K; Richter B; Kommoss S; Hauptmann S;
Eur J Cancer; 2013 May; 49(8):1905-14. PubMed ID: 23490647
[TBL] [Abstract][Full Text] [Related]
9. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Epidemiology and Risk Factors of Relapse, Follow-up and Interest of a Completion Surgery].
Margueritte F; Sallee C; Lacorre A; Gauroy E; Larouzee E; Chereau E; De La Motte Rouge T; Koskas M; Gauthier T
Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):248-259. PubMed ID: 32004784
[TBL] [Abstract][Full Text] [Related]
10. [Retrospective analysis of the clinical outcomes in 12 recurrent borderline ovarian tumor patients with second fertility-sparing surgery].
Chen R; Zhu T; Yu H; Zhu J; Lu X
Zhonghua Fu Chan Ke Za Zhi; 2014 Apr; 49(4):254-9. PubMed ID: 24969331
[TBL] [Abstract][Full Text] [Related]
11. Preoperative CA-125 Values as a Predictive Factor for the Postoperative Outcome in Primary Serous Ovarian Cancer.
Muallem MZ; Parashkevova A; Almuheimid J; Richter R; Diab Y; Braicu EI; Sehouli J
Anticancer Res; 2017 Jun; 37(6):3157-3161. PubMed ID: 28551658
[TBL] [Abstract][Full Text] [Related]
12. Serous and mucinous borderline ovarian tumours: differences in clinical presentation, high-risk histopathological features, and lethal recurrence rates.
Vasconcelos I; Darb-Esfahani S; Sehouli J
BJOG; 2016 Mar; 123(4):498-508. PubMed ID: 26705090
[TBL] [Abstract][Full Text] [Related]
13. The diagnostic challenge of ovarian carcinoma in normal-sized ovaries: a report of two cases.
Yong SL; Dahian S; Ramlan AH; Kang M
Horm Mol Biol Clin Investig; 2018 Aug; 35(1):. PubMed ID: 30098285
[TBL] [Abstract][Full Text] [Related]
14. Serum CA19.9 levels are commonly elevated in primary ovarian mucinous tumours but cannot be used to predict the histological subtype.
Kelly PJ; Archbold P; Price JH; Cardwell C; McCluggage WG
J Clin Pathol; 2010 Feb; 63(2):169-73. PubMed ID: 20154039
[TBL] [Abstract][Full Text] [Related]
15. [Borderline tumors : diagnosis and management : report of 10 cases].
Souki DZ; Bouchahda H; Limem W; Mahjoub S; Zakraoui MA; Ben Hmid R; Zouari F
Tunis Med; 2010 May; 88(5):312-6. PubMed ID: 20517826
[TBL] [Abstract][Full Text] [Related]
16. Hypoxic status in ovarian serous and mucinous tumors: relationship between histological characteristics and HIF-1alpha/GLUT-1 expression.
Iida T; Yasuda M; Miyazawa M; Fujita M; Osamura RY; Hirasawa T; Muramatsu T; Murakami M; Saito K; Mikami M
Arch Gynecol Obstet; 2008 Jun; 277(6):539-46. PubMed ID: 18026974
[TBL] [Abstract][Full Text] [Related]
17. Feasibility of ovarian cryopreservation in borderline ovarian tumours.
Fain-Kahn V; Poirot C; Uzan C; Prades M; Gouy S; Genestie C; Duvillard P; Morice P
Hum Reprod; 2009 Apr; 24(4):850-5. PubMed ID: 19098070
[TBL] [Abstract][Full Text] [Related]
18. Unilateral cystectomy and serous histology are associated with relapse in borderline ovarian tumor patients with fertility-sparing surgery: a systematic review and meta-analysis.
Li N; Ming X; Li Z
Arch Gynecol Obstet; 2020 Nov; 302(5):1063-1074. PubMed ID: 32748055
[TBL] [Abstract][Full Text] [Related]
19. High grade serous carcinoma of the ovary with a yolk sac tumour component in a postmenopausal woman: report of an extremely rare phenomenon.
Varia M; McCluggage WG; Oommen R
J Clin Pathol; 2012 Sep; 65(9):853-4. PubMed ID: 22496516
[No Abstract] [Full Text] [Related]
20. [Fertility-sparing surgery in borderline ovarian tumours].
Pehlivanov B; Iamakov K; Ivancheva H
Akush Ginekol (Sofiia); 2015; 54(1):21-6. PubMed ID: 25909126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
